Elena Zamagni and Myeloma - Free people check

(1 - 21 from 26

)

multiplemyelomahub.com › medical-information › elena-zamagni-esh-...At ESH MM 2019, Elena Zamagni discussed the use of ...

multiplemyelomahub.com

2nd How to Diagnose & Treat Multiple Myeloma, 5–7 April 2019, Berlin, DE Elena Zamagni Bologna University ...

Elena Zamagni | ASH | New criteria for determining the role of...

multiplemyelomahub.com

Elena Zamagni talks about updated criteria related to the use of 18F-FDG PET/CT scan for determining MRD in multiple myeloma.

EHA | Novel agents for NDMM: EHA updates

multiplemyelomahub.com

· At the 24th Congress of the European Hematology Association (EHA), Elena Zamagni from the Bologna University School of Medicine, Bologna, IT, gives an update on novel agents for newly diagnosed multiple myeloma (NDMM).

books.google.com › booksMolecular Imaging in Multiple Myeloma

books.google.de

Imaging. Procedures? Elena Zamagni. The. Role. of. Imaging. in. Multiple. Myeloma. and. the. “Death”. of. Conventional. Radiography. Bone disease is the most ...

18th European Haematology Association (EHA) Congress by ecancer on...

itunes.apple.com

3, VideoUse of autologous stem cell transplant in multiple myeloma: Dr Elena Zamagni, Dr Elena Zamagni talks to ecancer about autologous stem cell transplant ...

3 Multiple Myeloma MPT - London Cancer Alliance

www.londoncanceralliance.nhs.uk

3 Multiple Myeloma Protocol Name: ... Lucio Catalano, Elena Zamagni, Maria Teresa Petrucci, Valerio De Stefano, Manuela Ceccarelli, Maria Teresa Ambrosini, ...

Image interpretation criteria for FDG PET/CT in multiple myeloma: a...

rd.springer.com

Elena Zamagni. 2; Annibale Versari. 3; Stephane Chauvie. 4; Andrea Bianchi. 5; Marco Rensi. 6; Marilena Bell ...

Diagnosis and detection of smouldering multiple myeloma ...

ecancer.org

Dr Elena Zamagni speaks to ecancer at the MyKE Myeloma meeting in Barcelona about the diagnostic techniques available in smouldering multiple myeloma. She emphasises the importance of using novel imaging techniques, rather than whole body …

Refining MRD analysis in myeloma: the role of PET-CT and ...

www.vjhemonc.com

Measurable residual disease (MRD) can be determined using a variety of techniques. However, the majority of trials perform bone marrow MRD evaluation, while few are determining the effectiveness of PET-CT and MRI. Here, Elena Zamagni, MD, PhD, from the University of Bologna, Bologna, Italy, explains some of the complications regarding interpreting patient MRD and how incorporating these ...

The evolution of imaging techniques for multiple myeloma ...

ecancer.org

Dr Elena Zamagni - Bologna University School of Medicine, Bologna, Italy Dr Zamagni speaks with ecancer at the Myeloma Knowledge Exchange about screening and imaging of myeloma. She discusses the changes in imaging techniques for multiple myeloma, noting the strengths and weaknesses of some ...

The use of imaging to determine MRD | VJHemOnc

www.vjhemonc.com

Elena Zamagni, MD, PhD from the University of Bologna, Bologna, Italy discusses the use of imaging techniques to determine measurable residual disease outside of the bone marrow in patients with multiple myeloma. PET-CT and functional MRI are two techniques currently in use and are being further investigated in clinical trials, as described by Dr Zamagni.

www.nature.com › blood cancer journal › articlesTreatment of patients with multiple myeloma progressing on ...

www.nature.com

Philippe Moreau ,; Elena Zamagni &; Maria-Victoria Mateos. Blood Cancer Journal volume 9, Article number: 38 (2019) Cite this article ...

All web results to the name "Elena Zamagni"

Results Of PET/CT Scans May Predict Survival In Multiple Myeloma ...

www.myelomabeacon.com

“[Our study shows] a clear identification of the prognostic relevance of PET/CT [along with] other more known prognostic factors such as chromosomal abnormalities,” said Dr. Elena Zamagni of the Bologna University School of ...

ASH 18: Elena Zamagni |Int'l Myeloma Foundation

www.myeloma.org

ABOUT ELENA ZAMAGNI, MD PhD. Elena Zamagni MD, PhD, is an Assistant Professor of Hematology at the University of Bologna, Italy. She received her medical degree from the University of Bologna. She has published over 90 papers in peer-reviewed journals, mainly in the field of plasma cell dyscrasia. She is an active member of the board of the ...